It's too soon to tell, but reading the angry reactions around the web, it might be that the decision by Susan G. Komen for the Cure to withdraw hundreds of thousands of dollars in grants to Planned Parenthood ends up costing the Susan G. Komen people a lot more than it costs Planned Parenthood.

I would recommend Barbara Ehrenreich's 2001 essay "Welcome to Cancerland":

More so than in the case of any other disease, breast-cancer organizations and events feed on a generous flow of corporate support. Nancy Brinker [then the head of the Susan G. Komen Foundation] relates how her early attempts to attract corporate interest in promoting breast cancer "awareness" were met with rebuff. A bra manufacturer, importuned to affix a mammogram-reminder tag to his product, more or less wrinkled his nose. Now breast cancer has blossomed from wallflower to the most popular girl at the corporate charity prom. While AIDS goes begging and low-rent diseases like tuberculosis have no friends at all, breast cancer has been able to count on Revlon, Avon, Ford, Tiffany, Pier 1, Estee Lauder, Ralph Lauren, Lee Jeans, Saks Fifth Avenue, JC Penney, Boston Market, Wilson athletic gear -- and I apologize to those I've omitted. You can "shop for the cure" during the week when Saks donates 2 percent of sales to a breast-cancer fund; "wear denim for the cure" during Lee National Denim Day, when for a $5 donation you get to wear blue jeans to work. You can even "invest for the cure," in the Kinetics Assets Management's new no-load Medical Fund, which specializes entirely in businesses involved in cancer research.

Your comment will be posted after it is approved.

Leave a Reply.